Immunization

 
Immunization Levels Disheartening This Flu Season, Says William Schaffner, MD
February 07, 2023

Vaccine uptake this respiratory virus season is lagging compared to previous years, says Schaffner, medical director of the National Foundation for Infectious Diseases.

Respiratory Tripledemic 2022-23: Expert Update, Top Challenges
January 31, 2023

Distinguishing between influenza, COVID-19, and RSV and persuading vaccine-weary patients to get vaccinated are some of the challenges this season, says William Schaffner, MD.

CDC Releases First Estimates of Bivalent mRNA COVID-19 Booster Effectiveness against XBB/XBB.1.5
January 25, 2023

Preliminary estimates showed relative bivalent booster dose vaccine effectiveness against XBB/XBB.1.5 for at least the first 3 months after vaccination.

ACIP 2023 Vaccination Schedule Update, At-a-Glance
January 04, 2023

Among the CDC vaccine advisory group's recommendations are adding COVID-19 vaccines to the Vaccine for Children program and allowing PCV20 shots for those who previously received PCV13.

Daily Dose: Bivalent Boosters Protect Against Severe COVID-19 Disease
December 20, 2022

Your daily dose of clinical news you may have missed.

Daily Dose: Parent-Pediatrician Vaccine Discussions Lagging?
November 29, 2022

Your daily dose of clinical news you may have missed.

Parent-Pediatrician Vaccine Discussions are Lagging, National Poll Finds
November 28, 2022

One in 7 parents have not discussed vaccines with their child's primary clinician during the 2-year pandemic period, according to a CS Mott Children's Hospital poll.

Investigational Fentanyl Vaccine Could Block the Opioid from the Brain
November 15, 2022

A vaccine against fentanyl could stop the intense euphoria the drug creates and also block dangerous physiologic responses like respiratory depression, a new study suggests.

Pediatric RSV Vaccines: Why Are We Still Waiting?
November 08, 2022

I have admitted infants to the hospital every winter for 40 years, yet I still don't have good answers for anxious parents watching their child struggling to breathe.

Maternal RSV Vaccine Prevents Infection in Infants, Pfizer Announces
November 02, 2022

Topline phase 3 trial data showed 81.8% efficacy for the maternal vaccine against severe RSV-related illness in infants from birth through first 90 days of life.